IGC Pharma Inc (IGC)

IGC Pharma Revenue

IGC Pharma had revenue of $1.22M in the twelve months ending December 31, 2023, with 40.09% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $204.00K, a -38.55% decrease year-over-year. In the fiscal year ending March 31, 2023, IGC Pharma had annual revenue of $911.00K with 129.47% growth.

• Revenue (ttm): $1.22M
• Revenue Growth: +40.09%
• P/S Ratio: 25.06
• Revenue / Employee: $19,934
• Employees: 61
• Market Cap: 30.48M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	911.00K	514.00K	129.47%
Mar 31, 2022	397.00K	-501.00K	-55.79%
Mar 31, 2021	898.00K	-3.17M	-77.95%
Mar 31, 2020	4.07M	-1.04M	-20.41%
Mar 31, 2019	5.12M	2.92M	133.29%
Mar 31, 2018	2.19M	1.61M	277.86%
Mar 31, 2017	580.37K	-5.79M	-90.88%
Mar 31, 2016	6.37M	-1.31M	-17.10%
Mar 31, 2015	7.68M	5.41M	237.87%
Mar 31, 2014	2.27M	-5.76M	-71.69%
Mar 31, 2013	8.03M	3.83M	91.21%
Mar 31, 2012	4.20M	125.63K	3.08%
Mar 31, 2011	4.07M	-13.82M	-77.24%
Mar 31, 2010	17.90M	-17.44M	-49.35%
Mar 31, 2009	35.34M	33.15M	1,515.10%
Mar 31, 2008	2.19M	-	-
Mar 31, 2007	0	-	-
Mar 31, 2006	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.